ArticleWorld journal of oncology2025

Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis.

Shreya Shambhavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.